Description
The BD IMag™ Human NK Cell Enrichment Set - DM is used for the negative selection of Natural Killer (NK) cells from peripheral blood. The Biotinylated Human NK Cell Enrichment Cocktail contains monoclonal antibodies that recognize antigens expressed on erythrocytes, platelets, and peripheral leukocytes (including NK-T cells) that are not NK cells. The BD IMag™ Streptavidin Particles Plus - DM are magnetic nanoparticles that have streptavidin covalently conjugated to their surfaces. With these two components, the BD IMag™ Human NK Cell Enrichment Set -DM avoids the inadvertent activation of the enriched NK cells by using reagents that do not directly bind to those NK cells. This Enrichment Set has been optimized for use with the BD IMag™ Cell Separation Magnet, and it contains sufficient reagents to label 10^9 peripheral blood mononuclear cells (PBMC).
The NK Cell Enrichment Cocktail component is comprised of the following biotin-conjugated monoclonal antibodies:
Anti-human CD3, clone UCHT1
Anti-human CD19, clone HIB19
Anti-human CD36, clone CB38 (NL07)
Anti-human CD41a, clone HIP8
Anti-human CD66b, clone G10F5
Anti-human CD123 (IL-3 Receptor α chain), clone 9F5
Anti-human CD235a (Glycophorin A), clone GA-R2 (HIR2)
Anti-human IgE, clone G7-26
Components
| Part No. | Description | Size |
|---|---|---|
| 51-9000810 | Streptavidin Particles Plus - DM | NA |
| 51-9002893 | Biotinylated Human NK Cell Enrichment Cocktail | 5mL (1 ea) |
Format
- FormatBD IMag™-DM
Other Formats→
- Purified
Suggested Companion Products
Cell Separation Magnet RUO Cat No: 552311
APC Mouse Anti-Human CD56 B159RUO 100TestsCat No: 555518
PE Mouse Anti-Human CD3 UCHT1 (also known as UCHT-1; UCHT 1)RUO 100TestsCat No: 555333
PE Mouse Anti-Human CD19 HIB19RUO 100TestsCat No: 555413
PE Mouse Anti-Human CD36 CB38 (also known as NL07)RUO 100TestsCat No: 555455
PE Mouse Anti-Human CD123 9F5RUO 0.2mgCat No: 555644
PE Mouse Anti-Human CD235a GA-R2 (HIR2)RUO 0.1mgCat No: 555570
Propidium Iodide Staining Solution RUO 2mLCat No: 556463
Buffer (10X) RUO 100mLCat No: 552362
| Resources & Tools | ||||||
|---|---|---|---|---|---|---|
| SpectrumViewer | Download TDS | Regulatory Document Website | ||||
Preparation and Storage
Store undiluted at 4°C.The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.The antibody was conjugated with biotin under optimum conditions, and unreacted biotin was removed.Antibody or streptavidin was conjugated to the magnetic particles under optimum conditions, and unconjugated antibody/streptavidin was removed.
Product Notices
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- BD IMag™ particles are prepared from carboxy-functionalized magnetic particles which are manufactured by Skold Technology and are licensed under US patent number 7,169,618.
- Ficoll-Paque is a trademark of Amersham Biosciences Limited.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- Source of all serum proteins is from USDA inspected abattoirs located in the United States.
The detailed Magnetic Labeling and Enrichment Protocol follows. In summary, the Biotinylated Human NK Cell Enrichment Cocktail simultaneously stains erythrocytes, platelets, and most leukocytes except the NK cells. After washing away excess antibody, BD IMag™ Streptavidin Particles Plus - DM are added to the cell suspension and bind the cells bearing the biotinylated antibodies. The tube containing this labeled cell suspension is then placed within the magnetic field of the BD IMag™ Cell Separation Magnet (Cat. No. 552311). Negative selection is then performed to enrich for the unlabeled NK cells. Labeled cells migrate toward the magnet (positive fraction), leaving the unlabeled cells in suspension so they can be drawn off and retained (enriched fraction). The negative selection is repeated twice to increase the yield of the enriched fraction. If greater purity is required, negative selection may be performed on the enriched fraction. For clarification of the procedure, the magnetic separation steps are diagrammed in the Enrichment Flow Chart. The positive and enriched fractions can be evaluated in downstream applications such as flow cytometry and tissue culture. The antibodies in the Biotinylated Human NK Cell Enrichment Cocktail have been optimized and pre-diluted to provide maximum efficiency for enrichment of NK cells from PBMC.
MAGNETIC LABELING AND ENRICHMENT PROTOCOL
1.Prepare 1X BD IMag™ buffer: Dilute BD IMag™ Buffer (10X) (Cat. No. 552362) 1:10 with sterile distilled water or prepare Phosphate Buffered Saline (PBS) supplemented with 0.5% BSA, 2 mM EDTA, and 0.1% sodium azide.
1.Prepare PBMC from anti-coagulated human blood, preferably by density gradient centrifugation using Ficoll-Paque™.
2.Remove clumps of cells and/or debris by passing the suspension through a 70-µm nylon cell strainer. Count the cells, and res uspend them in 1X BD IMag™ buffer at a concentration of 10 x 10^6 cells/ml.
3.Add the Biotinylated Human NK Cell Enrichment Cocktail at 5 µl per 1 x 10^6 cells, and incubate at room temperature for 15 minutes.†
4.Wash the labeled cells with a 10X excess volume of 1X BD IMag™ buffer, centrifuge at 300 × g for 7 minutes, and carefully aspirate ALL the supernatant.
5.Vortex the BD IMag™ Streptavidin Particles Plus - DM thoroughly, and add 5 µl of particles for every 1 x 10^6 total cells.
6.MIX THOROUGHLY. Incubate at room temperature for 30 minutes.†
7.Bring the labeling volume up to a concentration of 20-80 x 10^6 cells/ml with 1X BD IMag buffer.
8.Transfer the labeled cells to a 12 x 75 mm round-bottom test tube, maximum volume added not to exceed 1.0 ml. Place this positive-fraction tube on the Cell Separation Magnet (horizontal position) for 6 to 8 minutes.
-For greater volume, transfer the cells to a 17 x 100 mm round-bottom test tube, maximum volume added not to exceed 3.0 ml. Place this positive-fraction tube on the Cell Separation Magnet (vertical position) for 8 minutes.
9.With the tube on the Cell Separation Magnet and using a sterile glass Pasteur pipette, carefully aspirate the supernatant (enriched fraction) and place in a new sterile tube.
10.Remove the positive-fraction tube from the Cell Separation Magnet, and add 1X BD IMag™ buffer to the same volume as in Step 8. Resuspend the positive fraction well by pipetting up and down 10 to 15 times, and place the tube back on the Cell Separation Magnet for 6 to 8 minutes.
-For 17 x 100 mm tube: Place on the Cell Separation Magnet for 8 minutes.
11.Using a new sterile Pasteur pipette, carefully aspirate the supernatant and combine with the enriched fraction from Step 10 above.
12.Repeat Steps 11 and 12. The combined enriched fraction contains NK cells with no bound antibodies or magnetic particles.
13.To increase the purity of the combined enriched fraction by another 5% or more (compare middle left and middle right panel in the figure), place the tube containing the combined enriched fraction on the Cell Separation Magnet for another 6 to 8 minutes.
-For 17 x 100 mm tube: Place on the Cell Separation Magnet for 8 minutes.
14.Carefully aspirate the supernatant and place in a new sterile tube. This is the twice-enriched fraction. The cells are ready to be processed for downstream applications.
15.The positive-fraction cells remaining in the original tube can be resuspended in an appropriate buffer or culture medium for downstream applications, including flow cytometry, if desired.
16.Samples of the total cell suspension and the positive and enriched fractions should be analyzed by flow cytometry to evaluate the efficiency of the cell-separation procedure.
* Hints for successful cell preparation:
- Draw the blood into a tube containing EDTA
- Remove the platelet rich plasma by centrifuging once at 220-240 × g.
- Wash 2-3 times in PBS after the density gradient separation.
- After the final wash, resuspend the cells at a relatively high concentration in 1X BD IMag™ buffer and proceed to Step 3.
† Avoid nonspecific labeling by working quickly and adhering to recommended incubation times.
